retatrutide triple agonist glp-1 gip glucagon phase 2 nejm 2023 just posted the biggest weight-loss numbers ever recorded for a drug โ 28.3% (โ70 lb) average in 3, with 45% of people hitting 30%+ loss, territory once reserved for bariatric ๐ง๐ต๐ฒ ๐๐ณ๐ณ๐ฒ๐ฐ๐ ๐ผ๐ณ ๐๐๐ฃ-๐ญ ๐ฅ๐ฒ๐ฐ๐ฒ๐ฝ๐๐ผ๐ฟ
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 6 - Aug 11


























